Rekah (REKA)

Currency in ILS
1,089
0(0.00%)
Closed·
REKA is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1,0891,097
52 wk Range
1,0061,348
Key Statistics
Bid/Ask
1,111.00 / 1,035.00
Prev. Close
1,089
Open
1,089
Day's Range
1,089-1,097
52 wk Range
1,006-1,348
Volume
11
Average Volume (3m)
3.42K
1-Year Change
-9.25%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
REKA Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Not profitable over the last twelve months

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Earnings

Latest Release
May 31, 2026
EPS / Forecast
-0.25 / --
Revenue / Forecast
79.31M / --
EPS Revisions
Last 90 days

REKA Income Statement

Compare REKA to Peers and Sector

Metrics to compare
REKA
Peers
Sector
Relationship
P/E Ratio
−6.7x10.6x−0.4x
PEG Ratio
0.010.000.00
Price/Book
0.9x1.0x2.6x
Price / LTM Sales
0.4x0.6x3.0x
Upside (Analyst Target)
-127.3%50.8%
Fair Value Upside
Unlock21.3%9.4%Unlock

Rekah Pharmaceutical Industry Ltd. engages in the manufacture, marketing, sale, and distribution of pharmaceuticals, cosmetics, vitamins and nutritional supplements, and medical devices in Israel. The company offers steroids, antibiotics, and ophthalmic products, as well as dermo-cosmetics products. Its portfolio of products comprise Rx and OTC drugs, and medical devices used in various therapeutic fields, such as urinary tract pain, steroid anti-inflammatories, cough, expectoration and bronchitis, motion sickness, runny nose and congestion, skin disinfection, wounds, burns and insect bites, eye infections, glaucoma, dryness, allergies, fever and pain relief, mouth, depression and anxiety, muscle and joint pain, antibiotics, fungal infections, anemia and nutritional deficits, ear pain, babies and children, etc. The company was founded in 1947 and is based in Holon, Israel.

Employees
390
Market
Israel

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
185.11K1.62%2.02M
Other Institutional Investors
9.83M86.13%107.07M
Public Companies & Retail Investors
1.40M12.25%15.22M
Total
11.41M100.00%124.31M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
FIMI Management Ltd43.07%4,915,78453,533
FIMI V43.07%4,915,78453,533

FAQ

What Is the Rekah (REKA) Stock Price Today?

The Rekah stock price today is 1,089 ILS.

What Stock Exchange Does Rekah Trade On?

Rekah is listed and trades on the Tel Aviv Stock Exchange.

What Is the Stock Symbol for Rekah?

The stock symbol for Rekah is "REKA."

What Is the Rekah Market Cap?

As of today, Rekah market cap is 124.31M ILS.

What Is Rekah's Earnings Per Share (TTM)?

The Rekah EPS (TTM) is -2.

From a Technical Analysis Perspective, Is REKA a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Rekah Stock Split?

Rekah has split 0 times.

How Many Employees Does Rekah Have?

Rekah has 390 employees.

What is the current trading status of Rekah (REKA)?

As of Jul 18, 2026, Rekah (REKA) is trading at a price of 1,089 ILS, with a previous close of 1,089 ILS. The stock has fluctuated within a day range of 1,089 ILS to 1,097 ILS, while its 52-week range spans from 1,006 ILS to 1,348 ILS.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.